January 27, 2025 — IRVINE, CA / January 27, 2025 / Afecta Pharmaceuticals has officially on-boarded Transcell, a next-generation biologics company based in Hyderabad, India, for Digital Animal Replacement Technology (DART) as part of Afecta’s commitment to enhance its drug development programs. The implementation of DART is poised to significantly accelerate Afecta’s clinical development focused on neurodegenerative diseases, ophthalmology and oncology.